Saudi Chemical unit signs non-binding MoU with Cypriot’s Remedica

08/10/2024 Argaam
Logo ofAja Pharma Pharmaceutical Industries

Logo of Aja Pharma Pharmaceutical Industries

Saudi Chemical Company Holding’s (SCCH) pharmaceutical division Aja Pharma Pharmaceutical Industries has signed a non-binding memorandum of understanding (MoU) with Remedica Ltd., a Cypriot pharmaceutical company.

 

The MoU aims to develop and enhance a range of pharmaceutical products and provide high-quality, innovative medicines, the company said in a statement on Tadawul.

 

For more news on listed companies

 

The signing took place during the CPHI Worldwide Exhibition in Milan, Italy, where Aja Pharma participated under the Saudi Export Development Authority.

 

The partnership seeks to combine the strengths of both companies to drive innovation and enter new markets, the statement added.

 

Aja Pharma and Remedica will collaborate to develop medicines and transfer technology, focusing on cardiovascular, diabetes, infections, and oncology treatments in tablet and injection forms.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.